Goto M, Hosako Y, Katayama M, Yamada T
Division of Rheumatic Diseases, Tokyo Metropolitan Otasuka Hospital, Japan.
Int J Clin Pharmacol Res. 1993;13(3):161-6.
A high-molecular-weight sodium hyaluronate (commercial name Artz) was serially injected biweekly for 12 weeks into 9 knee joints from 8 patients with active rheumatoid arthritis (RA) and certain clinical and biochemical parameters were monitored. Three of these parameters, namely specific viscosity, concentration of HA, and stringency, were significantly increased by the intra-articular injection of Artz. Clinically, the majority of the knees (7 out of 9 injected) showed a relief from pain and no joint fluid could be drawn from 4 of the knees after 12 weeks following the initial injection. Both the fluid volume collected and the molecular weight of hyaluronate in the synovial fluid showed some improvement, but it was not statistically significant. No improvement of systemic inflammatory parameters such as erythrocyte sedimentation rate and C reactive protein were observed. Injectable Artz sodium hyaluronate was effective for the treatment of local inflammation in RA.
将一种高分子量透明质酸钠(商品名Artz)每两周连续注射一次,共12周,注射到8例活动性类风湿关节炎(RA)患者的9个膝关节中,并监测某些临床和生化参数。关节内注射Artz后,其中三个参数,即比粘度、HA浓度和粘度,显著增加。临床上,大多数膝关节(9个注射膝关节中的7个)疼痛缓解,初次注射后12周,4个膝关节无法抽出关节液。收集的液体量和滑液中透明质酸的分子量均有一定改善,但无统计学意义。未观察到全身炎症参数如红细胞沉降率和C反应蛋白的改善。可注射的Artz透明质酸钠对RA局部炎症治疗有效。